Cerecin Inc.

New Filing
CIK: 0001293610·Biotechnology·DELAWARE·Filed: Aug 18, 2022
Total Offering

$39,999,999

Amount Sold

$7,220,002

Investors

1

First Sale

Aug 3, 2022

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Nicholas Charles Stacey
Related Person
Samuel T. Henderson
Related Person
Jerris Knaisch
Related Person
Claude Nash
Related Person
Wolfgang Reichenberger
Related Person
Gurpreet Singh Vohra
Related Person
Hans-Jurgen Woerle
Related Person
KiKab Kim
Related Person
Milan Vinnola
Related Person

Company

Accera Inc

44 COOK STREET

DENVER, CO, 80206

(303) 999-3700

SEC Filing

0001293610-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cerecin Inc. Form D Filing — $39,999,999 | FilingFlow